Home › Pagkabigo ng Puso
Pag-aaral pangklinika para sa Pagkabigo ng Puso na nagre-recruit sa U.S.
224 pag-aaral para sa Pagkabigo ng Puso ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- New York City, NY51 pag-aaral
- Boston, MA46 pag-aaral
- Dallas, TX42 pag-aaral
- Houston, TX35 pag-aaral
- Cleveland, OH31 pag-aaral
- Philadelphia, PA31 pag-aaral
- San Francisco, CA29 pag-aaral
- Chicago, IL28 pag-aaral
- Durham, NC25 pag-aaral
- Kansas City, MO25 pag-aaral
- St. Louis, MO24 pag-aaral
- Indianapolis, IN24 pag-aaral
- Atlanta, GA23 pag-aaral
- Baltimore, MD23 pag-aaral
- San Diego, CA22 pag-aaral
- Cincinnati, OH22 pag-aaral
- Minneapolis, MN22 pag-aaral
- Rochester, MN21 pag-aaral
- Ann Arbor, MI21 pag-aaral
- Los Angeles, CA20 pag-aaral
- Jacksonville, FL20 pag-aaral
- Washington, DC20 pag-aaral
- Nashville, TN19 pag-aaral
- Pittsburgh, PA18 pag-aaral
- Tampa, FL18 pag-aaral
- Salt Lake City, UT17 pag-aaral
- Aurora, CO17 pag-aaral
- Austin, TX17 pag-aaral
- Richmond, VA17 pag-aaral
- Portland, OR17 pag-aaral
- Orlando, FL16 pag-aaral
- Charleston, SC16 pag-aaral
- Seattle, WA16 pag-aaral
- Phoenix, AZ16 pag-aaral
- Arlington, VA15 pag-aaral
- Harrisburg, PA15 pag-aaral
- Milwaukee, WI15 pag-aaral
- Columbus, OH14 pag-aaral
- New Haven, CT14 pag-aaral
- Detroit, MI14 pag-aaral
Ayos sa estado
- Alabama20 pag-aaral
- Arizona29 pag-aaral
- Arkansas12 pag-aaral
- California66 pag-aaral
- Colorado22 pag-aaral
- Connecticut22 pag-aaral
- Delaware3 pag-aaral
- District of Columbia13 pag-aaral
- Florida51 pag-aaral
- Georgia26 pag-aaral
- Idaho6 pag-aaral
- Illinois44 pag-aaral
- Indiana30 pag-aaral
- Iowa10 pag-aaral
- Kansas17 pag-aaral
- Kentucky19 pag-aaral
- Louisiana17 pag-aaral
- Maine5 pag-aaral
- Maryland27 pag-aaral
- Massachusetts47 pag-aaral
- Michigan37 pag-aaral
- Minnesota43 pag-aaral
- Mississippi7 pag-aaral
- Missouri40 pag-aaral
- Nebraska19 pag-aaral
- Nevada4 pag-aaral
- New Jersey27 pag-aaral
- New Mexico5 pag-aaral
- New York57 pag-aaral
- North Carolina41 pag-aaral
- Ohio53 pag-aaral
- Oklahoma21 pag-aaral
- Oregon17 pag-aaral
- Pennsylvania45 pag-aaral
- Rhode Island3 pag-aaral
- South Carolina29 pag-aaral
- South Dakota15 pag-aaral
- Tennessee32 pag-aaral
- Texas67 pag-aaral
- Utah22 pag-aaral
- Vermont7 pag-aaral
- Virginia37 pag-aaral
- Washington25 pag-aaral
- West Virginia8 pag-aaral
- Wisconsin18 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Nagre-recruitPhase 2/3
29 Days – 17 Years · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT05714085Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT06552637A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction
Nagre-recruitPhase 1
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07465653A Study to Evaluate the Safety and Efficacy of AC01 Compared to Placebo in Participants With Chronic Heart Failure
Nagre-recruitPhase 2
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07584967A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06424288A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06935370INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery
Nagre-recruit
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06965504Left vs Left Randomized Clinical Trial
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT05650658A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
Nagre-recruit
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07214376PrEcision Pacing in HFpEF: the PEP-HFpEF Trial
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07864558Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07232030Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT06526195Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes
Nagre-recruit
Lahat ng edad · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT06593314Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT00271180SWITCH: Apixaban vs Vitamin K in HM3
Nagre-recruitPhase 3
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07471139A Study of LY3971297 in Participants With Heart Failure
Nagre-recruitPhase 1
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07547540Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Nagre-recruitPhase 3
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06736574Evaluating a Digital Aid to Improve ICD Decisions
Nagre-recruit
Edad 60 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07913204Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07069738ELEVATE-HFpEF Clinical Study
Nagre-recruit
Edad 40 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT06678841Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Nagre-recruitPhase 3
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT07037459A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Nagre-recruitPhase 3
Hanggang edad 18 · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT07192952Voice-based Outcome Identification and Clinical Evaluation in Heart Failure
Nagre-recruitObservasyonal na pag-aaral
Edad 22 pataas · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT07870395CCM OPEN HF Registry
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT07112924Cardiogenic Shock Working Group Registry
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT04682483Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.